🟢 Gossamer Bio is trading 7.02% up in pre-market with no confirmed overnight catalyst

Gossamer Bio is trading at $0.19 (+7.02%) in pre-market, with the move appearing speculative or liquidity-driven.

• No new August 27, 2026 company-specific announcement was identified.
• The latest major development remains Gossamer Bio’s financing of up to $250 million, including $150 million in committed capital, previously raising dilution concerns.
• Broader futures are higher, but no clear evidence links that sentiment directly to Gossamer Bio.